Cytarabine 1,000 mg, for intravenous or subcutaneous injection, Kocak Ilac, Turkey Order Cytarabine 1,000 mg, for intravenous or subcutaneous injection, Kocak Ilac, Turkey. Medicine delivery from Europe within 4-5 days with storage conditions maintained. Payment on delivery. Order at +380996042415 via Viber or WhatsApp.
- Delivery of non-temperature-controlled medicines to Chisinau - $25.
Delivery of temperature-controlled medicines to Chisinau - $50.
Up to 5 packages can be sent per shipment. The price applies to one shipment. - Pickup from Odesafree
- Shipping within Ukraine by Nova Poshta at the carrier's rates.
Payment in UAH upon receipt of the order.
Delivery time
- Originator medicines: 5-7 days
- Generic medicines: 3-4 days
- Bank transfer to the settlement account after receiving the order
- Payment upon pickup in Odesa
Interchangeable drugs with the same active ingredients substance:
Alexan
Wiztar
Laracite
Cytarabine
Cytarabine-Health
Cytosar
Tsitazar
Indications:
Achieving and maintaining remission in acute non-lymphoblastic leukemia in adults and children.
Treatment of other types of leukemia, such as acute lymphocytic leukemia, chronic myeloblastic leukemia (blast crisis).
Prevention or treatment of leukemic meningitis intrathecally as monotherapy or in combination with other drugs (methotrexate, hydrocortisone).
Cytarine® can be used as monotherapy or in combination with other antineoplastic agents; The best results are usually achieved with complex treatment. Remissions induced by the drug cytarin ® are short-term without further maintenance therapy.
Treatment of leukemia with a high risk of complications, refractory leukemia and relapse of acute leukemia, regardless of concomitant use antitumor chemotherapeutic agents with high doses of the drug.
As part of combination therapy (LSA2L2) for the treatment of non-Hodgkin's lymphomas in children.
Cytarine®was experimentally used to treat various types of neoplasms. The result of the research was the following observation:a small number of patients with solid tumors had a positive response to treatment.
